Your browser doesn't support javascript.
loading
The Association between Ovarian Hyperstimulation Syndrome and Pregnancy Complications following Fertility Treatments.
Vainer-Rotbart, Shirah; Sheiner, Eyal; Harlev, Avi; Bar, Guy; Levy, Amalia.
Afiliação
  • Vainer-Rotbart S; Department of Public Health, Faculty of Health Sciences Ben Gurion University of the Negev, Givatayim, Israel.
  • Sheiner E; Department of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Harlev A; Fertility and IVF Unit, Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Bar G; Department of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Levy A; Department of Public Health, Faculty of Health Sciences Ben Gurion University of the Negev, Givatayim, Israel.
Am J Perinatol ; 40(10): 1088-1095, 2023 07.
Article em En | MEDLINE | ID: mdl-34327685
OBJECTIVE: This study was aimed to assess the association between ovarian hyperstimulation syndrome (OHSS) and pregnancy complications among women who conceived following fertility treatment. STUDY DESIGN: A retrospective population-based cohort study, including all singleton deliveries of patients conceived following ovulation induction (OI) or in vitro fertilization (IVF) between 1988 and 2016, was conducted. All births occurred in a single tertiary medical center. A comparison was performed between deliveries of women who had experienced OHSS at early gestation and subsequently had a pregnancy and women without OHSS. Women lacking prenatal care, multiple gestations, and stillbirths were excluded from the analyses. A multivariable logistic regression model was used to control for confounders. RESULTS: During the study period, 351,373 deliveries met the inclusion criteria, of which 6,748 were deliveries of infants who were conceived by either IVF or OI. Of this study population, 105 cases (1.6%) composed the exposed group, that is, women who had experienced OHSS with a subsequent live birth. In the multivariate analyses, after controlling for confounders, OHSS was not found as an independent risk factor for preeclampsia, gestational diabetes mellitus (GDM), intrauterine growth restriction (IUGR), preterm delivery (both <37 and <34 weeks), low birth weight (LBW), very LBW (VLBW), small for gestational age (SGA), and caesarean delivery. In a subanalysis conducted solely on the IVF population, similar results were found, aside from the association between OHSS and preterm delivery before 34 weeks of gestation which was statistically significant (adjusted odds ratio [AOR] = 2.3 95% confidence interval [CI]: 1.0-5.3, p = 0.049). CONCLUSION: In our population, OHSS was not found as a risk factor for adverse pregnancy and perinatal outcome. In IVF patients, OHSS is a risk factor for preterm delivery before 34 weeks of gestation. KEY POINTS: · OHSS is not a risk factor for pregnancy complications.. · Complications investigated were preeclampsia, GDM, prematurity, and others.. · In IVF patients, OHSS is a risk factor for preterm delivery..
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Complicações na Gravidez / Síndrome de Hiperestimulação Ovariana / Diabetes Gestacional / Nascimento Prematuro Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Complicações na Gravidez / Síndrome de Hiperestimulação Ovariana / Diabetes Gestacional / Nascimento Prematuro Idioma: En Ano de publicação: 2023 Tipo de documento: Article